Compare HCA Health Inc (HCA) vs Procter & Gamble Co (PG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
HCA Health Inc vs Procter & Gamble Co — how do they compare? HCA Health Inc trades at $372.15 (market cap $82.17B), while Procter & Gamble Co trades at $148.03 (market cap $347.26B). The key difference: Procter & Gamble Co is far larger — about 4.2× HCA Health Inc's market cap, and Procter & Gamble Co pays the higher dividend (2.92%). Which is the better fit depends on your goals.
| HCA | PG | |
|---|---|---|
Market Cap | $82.17B | $347.26B |
Sector | Health | Consumer Staples |
52-Week High | $545.13 | $167.18 |
52-Week Low | $334.32 | $138.10 |
Enterprise Value | $131.08B | $372.74B |
Dividend Yield | 0.84% | 2.92% |
Volume | — | 6,423,436 |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
HCA Healthcare trades at $370.74, down 0.12% on the day, with a bearish technical signal but strong fundamentals including consistent earnings beats and revenue growth to $75.6 billion in 2025. The stock faces headwinds from lowered 2026 guidance and negative news flow, but maintains a solid valuation with a P/E of 12.79 and positive analyst consensus.
The outlook is mixed: attractive valuation and operational strength support upside to the $469.40 price target, but near-term risks from payer mix shifts and legal investigations warrant caution. Long-term growth drivers include capacity expansion and medical advancements, though investor sentiment is currently pressured.
Procter & Gamble (PG) trades at $147.67, down 1.53% on the day, as the consumer staples giant shows mixed signals. The stock maintains a bullish technical outlook with strong moving average support, while fundamentals reveal steady revenue growth to $84.28B in 2025 and improving net income margins to 19.16%. Recent quarterly earnings have consistently beaten expectations, and the company continues its dividend reliability with $1.09 quarterly payouts. Analyst consensus remains positive with a $161.71 price target, though premium valuations warrant monitoring.
PG presents a stable investment case with defensive characteristics amid market volatility. The company's consistent earnings beats, strong cash flow generation ($17.82B operating cash flow in 2025), and 69-year dividend growth streak support long-term value. However, premium valuation multiples (P/E 21.8, P/S 4.18) and modest revenue growth create near-term headwinds. Investors should weigh the security of steady dividends against valuation concerns in a challenging consumer environment.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About HCA Health Inc
HCA Healthcare is a Nashville-based healthcare provider organization operating the largest collection of acute-care hospitals in the U.S. As of December 2021, the firm owned and operated 182 hospitals, 125 freestanding outpatient surgery centers, and a broad network of physician offices, urgent care clinics, and freestanding emergency rooms across nearly 20 states and a small foothold in England.
Read more on HCA →About Procter & Gamble Co
The Procter & Gamble Company manufactures and markets consumer products in countries throughout the world. The Company provides products in the laundry and cleaning, paper, beauty care, food and beverage, and health care segments. Procter & Gamble products are sold primarily through mass merchandisers, grocery stores, membership club stores, drug stores, and neighborhood stores.
Read more on PG →
